Complete Response Letters
Verrica Pharmaceuticals Inc.: cantharidin
What FDA's Complete Response Letters to the company say, in the letters' own words.
Complete Response Letter, May 23, 2022
No complete sentence from this letter is available from the knowledge graph yet.
Complete Response Letter, Sep 16, 2021
No complete sentence from this letter is available from the knowledge graph yet.
Complete Response Letter, Jul 13, 2020
Cosmetic Act for cantharidin topical solution, 7%.
CRL_NDA212905_20200713:p1:s12Extractable/leachable studies you have committed to in the amendment dated January 23, 2020 should be conducted and the results of these studies should be submitted to the application.
CRL_NDA212905_20200713:p1:s28As you further develop your proposed product and prepare your next human factors study protocol to address the above concerns, we have the following additional recommendations:
CRL_NDA212905_20200713:p3:s3More Complete Response Letters
Updated Sep 30, 2026 · built from 283 companies in the EphemerisX knowledge graph. This page is regenerated as companies are added.